222 related articles for article (PubMed ID: 25008066)
21. Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.
Sankar S; Theisen ER; Bearss J; Mulvihill T; Hoffman LM; Sorna V; Beckerle MC; Sharma S; Lessnick SL
Clin Cancer Res; 2014 Sep; 20(17):4584-97. PubMed ID: 24963049
[TBL] [Abstract][Full Text] [Related]
22. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
[TBL] [Abstract][Full Text] [Related]
23. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.
Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK
Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820
[TBL] [Abstract][Full Text] [Related]
24. Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.
Gierisch ME; Pfistner F; Lopez-Garcia LA; Harder L; Schäfer BW; Niggli FK
J Biol Chem; 2016 Dec; 291(52):26922-26933. PubMed ID: 27875302
[TBL] [Abstract][Full Text] [Related]
25. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
[TBL] [Abstract][Full Text] [Related]
26. Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis.
Ma Y; Baltezor M; Rajewski L; Crow J; Samuel G; Staggs VS; Chastain KM; Toretsky JA; Weir SJ; Godwin AK
J Mol Med (Berl); 2019 Jul; 97(7):957-972. PubMed ID: 31025088
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
[TBL] [Abstract][Full Text] [Related]
28. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
29. Circulating Plasma Tumor DNA Is Superior to Plasma Tumor RNA Detection in Ewing Sarcoma Patients: ptDNA and ptRNA in Ewing Sarcoma.
Bodlak A; Chang K; Channel J; Treece AL; Donaldson N; Cost CR; Garrington TP; Greffe B; Luna-Fineman S; Sopfe J; Loeb DM; Hayashi M
J Mol Diagn; 2021 Jul; 23(7):872-881. PubMed ID: 33887462
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profile of ewing sarcoma cell lines differing in their EWS-FLI1 fusion type.
Bandrés E; Malumbres R; Escalada A; Cubedo E; González I; Honorato B; Zarate R; García-Foncillas J; de Alava E
J Pediatr Hematol Oncol; 2005 Oct; 27(10):537-42. PubMed ID: 16217257
[TBL] [Abstract][Full Text] [Related]
31. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
[TBL] [Abstract][Full Text] [Related]
32. Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis.
Talbot J; Brion R; Picarda G; Amiaud J; Chesneau J; Bougras G; Stresing V; Tirode F; Heymann D; Redini F; Verrecchia F
Biochim Biophys Acta; 2013 Apr; 1832(4):553-64. PubMed ID: 23313578
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.
Sheffield NC; Pierron G; Klughammer J; Datlinger P; Schönegger A; Schuster M; Hadler J; Surdez D; Guillemot D; Lapouble E; Freneaux P; Champigneulle J; Bouvier R; Walder D; Ambros IM; Hutter C; Sorz E; Amaral AT; de Álava E; Schallmoser K; Strunk D; Rinner B; Liegl-Atzwanger B; Huppertz B; Leithner A; de Pinieux G; Terrier P; Laurence V; Michon J; Ladenstein R; Holter W; Windhager R; Dirksen U; Ambros PF; Delattre O; Kovar H; Bock C; Tomazou EM
Nat Med; 2017 Mar; 23(3):386-395. PubMed ID: 28134926
[TBL] [Abstract][Full Text] [Related]
34. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor.
Athale UH; Shurtleff SA; Jenkins JJ; Poquette CA; Tan M; Downing JR; Pappo AS
J Pediatr Hematol Oncol; 2001 Feb; 23(2):99-104. PubMed ID: 11216714
[TBL] [Abstract][Full Text] [Related]
35. SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth.
Su S; Chen J; Jiang Y; Wang Y; Vital T; Zhang J; Laggner C; Nguyen KT; Zhu Z; Prevatte AW; Barker NK; Herring LE; Davis IJ; Liu P
Adv Sci (Weinh); 2021 Jul; 8(14):e2004846. PubMed ID: 34060252
[TBL] [Abstract][Full Text] [Related]
36. EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth.
Issaq SH; Mendoza A; Kidner R; Rosales TI; Duveau DY; Heske CM; Rohde JM; Boxer MB; Thomas CJ; DeBerardinis RJ; Helman LJ
Mol Cancer Ther; 2020 Jul; 19(7):1520-1529. PubMed ID: 32371575
[TBL] [Abstract][Full Text] [Related]
37. EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.
Shimizu R; Tanaka M; Tsutsumi S; Aburatani H; Yamazaki Y; Homme M; Kitagawa Y; Nakamura T
Cancer Sci; 2018 Sep; 109(9):2907-2918. PubMed ID: 29945296
[TBL] [Abstract][Full Text] [Related]
38. Review: Ewing Sarcoma Predisposition.
Gargallo P; Yáñez Y; Juan A; Segura V; Balaguer J; Torres B; Oltra S; Castel V; Cañete A
Pathol Oncol Res; 2020 Oct; 26(4):2057-2066. PubMed ID: 31656020
[TBL] [Abstract][Full Text] [Related]
39. Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.
Goss KL; Gordon DJ
Oncotarget; 2016 Sep; 7(39):63003-63019. PubMed ID: 27557498
[TBL] [Abstract][Full Text] [Related]
40. Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma.
Wang S; Huo X; Yang Y; Mo Y; Kollipara RK; Kittler R
Cancer Lett; 2023 Jan; 552():215984. PubMed ID: 36330954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]